CL2012000450A1 - Compuestos derivados de isoxazolidina de glucocorticoides, de la serie de los glucocorticoides; composicion farmaceutica; combinacion farmaceutica; proceso para su preparacion; y uso para disminuir la cantidad, acividad y movimiento de las celulas inflamatorias. - Google Patents

Compuestos derivados de isoxazolidina de glucocorticoides, de la serie de los glucocorticoides; composicion farmaceutica; combinacion farmaceutica; proceso para su preparacion; y uso para disminuir la cantidad, acividad y movimiento de las celulas inflamatorias.

Info

Publication number
CL2012000450A1
CL2012000450A1 CL2012000450A CL2012000450A CL2012000450A1 CL 2012000450 A1 CL2012000450 A1 CL 2012000450A1 CL 2012000450 A CL2012000450 A CL 2012000450A CL 2012000450 A CL2012000450 A CL 2012000450A CL 2012000450 A1 CL2012000450 A1 CL 2012000450A1
Authority
CL
Chile
Prior art keywords
isoxazolidine
glucocorticoid
series
glucocorticoids
decrease
Prior art date
Application number
CL2012000450A
Other languages
English (en)
Inventor
Elizabetta Armani
Eleonora Ghidini
Ilaria Peretto
Andrea Virdis
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41666572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000450(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of CL2012000450A1 publication Critical patent/CL2012000450A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos derivados de isoxazolidina, de la serie de los glucocorticoides; composición farmacéutica; combinación farmacéutica; y proceso para prepararlos.
CL2012000450A 2009-09-11 2012-02-21 Compuestos derivados de isoxazolidina de glucocorticoides, de la serie de los glucocorticoides; composicion farmaceutica; combinacion farmaceutica; proceso para su preparacion; y uso para disminuir la cantidad, acividad y movimiento de las celulas inflamatorias. CL2012000450A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09011665 2009-09-11

Publications (1)

Publication Number Publication Date
CL2012000450A1 true CL2012000450A1 (es) 2012-08-10

Family

ID=41666572

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000450A CL2012000450A1 (es) 2009-09-11 2012-02-21 Compuestos derivados de isoxazolidina de glucocorticoides, de la serie de los glucocorticoides; composicion farmaceutica; combinacion farmaceutica; proceso para su preparacion; y uso para disminuir la cantidad, acividad y movimiento de las celulas inflamatorias.

Country Status (27)

Country Link
US (1) US8637662B2 (es)
EP (2) EP2993178A1 (es)
JP (1) JP2013504524A (es)
KR (1) KR101451486B1 (es)
CN (2) CN105175479B (es)
AR (2) AR078164A1 (es)
AU (1) AU2010294598B2 (es)
BR (1) BR112012005503B1 (es)
CA (1) CA2773594C (es)
CL (1) CL2012000450A1 (es)
CO (1) CO6511204A2 (es)
EA (1) EA025191B1 (es)
GE (1) GEP20146135B (es)
IL (1) IL218539A (es)
JO (1) JO3760B1 (es)
MA (1) MA33561B1 (es)
ME (1) ME01331B (es)
MX (1) MX2012002967A (es)
MY (1) MY164842A (es)
NZ (1) NZ598662A (es)
PE (1) PE20120894A1 (es)
SG (2) SG10201608490VA (es)
TN (1) TN2012000077A1 (es)
TW (1) TWI494318B (es)
UA (1) UA108858C2 (es)
WO (1) WO2011029547A2 (es)
ZA (1) ZA201201705B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993178A1 (en) * 2009-09-11 2016-03-09 CHIESI FARMACEUTICI S.p.A. Glucocorticoid condensed in position 16,17 with an isoxazolidine group
TW201139369A (en) * 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
RU2013141933A (ru) 2011-03-15 2015-03-20 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные изоксазолидина
UA113508C2 (xx) 2011-03-15 2017-02-10 Ізоксазолідинові похідні
KR20140042886A (ko) * 2011-08-01 2014-04-07 키에시 파르마슈티시 엣스. 피. 에이. 피롤리딘 고리를 갖는 16,17 위치에서 응축된 항염증용 스테로이드
US9155747B2 (en) * 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
PL3231444T3 (pl) 2014-05-12 2020-05-18 Verona Pharma Plc Nowe leczenie
SG10202100596SA (en) 2014-09-03 2021-02-25 Rhizen Pharmaceuticals Sa Method of treatment and compositions comprising a dual pi3k delta-gamma kinase inhibitor and a corticosteroid
CN104262440B (zh) * 2014-09-10 2016-08-17 江西赣亮医药原料有限公司 一种16ɑ-羟基泼尼松龙的制备方法
CN109206471B (zh) * 2017-06-30 2022-07-12 天津药业研究院股份有限公司 一种哈西奈德的制备方法
CN109575096B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙产品的新方法
CN112142820A (zh) * 2019-06-29 2020-12-29 天津药业研究院股份有限公司 曲安奈德的合成方法
CN117050128B (zh) * 2023-08-15 2026-04-24 黄冈人福药业有限责任公司 一种11β-羟基-孕甾-1,4,16-三烯-3,20-二酮-21-醋酸酯的制备方法和设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1131213B (de) * 1958-06-13 1962-06-14 Syntex Sa Verfahren zur Herstellung neuer Pregnanverbindungen
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
BR6678983D0 (pt) * 1965-05-04 1973-09-18 Merck & Co Inc Processo para preparar 21-fosfato esteroides
SE307576B (es) * 1966-01-27 1969-01-13 Bofors Ab
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
GB1302572A (es) * 1969-05-05 1973-01-10
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
SE378110B (es) * 1972-05-19 1975-08-18 Bofors Ab
US4018774A (en) * 1976-02-13 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal [16α,17-d]isoxazolidines
DE3133631A1 (de) 1981-08-21 1983-03-03 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide ihre herstellung und verwendung
US5200518A (en) * 1991-02-21 1993-04-06 Kangweon National University Anti-inflammatory carboxycyclic acetal pregnane derivatives
JP2749778B2 (ja) * 1994-09-05 1998-05-13 日清食品株式会社 トリアムシノロン誘導体
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
GB0415747D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
RU2008100237A (ru) * 2005-06-14 2009-07-20 Джилид Сайэнс, Инк. (US) ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ
AR069804A1 (es) * 2007-12-21 2010-02-17 Schering Corp Agonistas del receptor glucocorticoide c20- c21 sustituido
CA2716476A1 (en) * 2008-02-27 2009-09-03 Astrazeneca Ab 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
EP2993178A1 (en) * 2009-09-11 2016-03-09 CHIESI FARMACEUTICI S.p.A. Glucocorticoid condensed in position 16,17 with an isoxazolidine group

Also Published As

Publication number Publication date
BR112012005503B1 (pt) 2021-10-13
US8637662B2 (en) 2014-01-28
CN102482318A (zh) 2012-05-30
TN2012000077A1 (en) 2013-09-19
ME01331B (me) 2013-12-20
MX2012002967A (es) 2012-04-30
CA2773594A1 (en) 2011-03-17
JP2013504524A (ja) 2013-02-07
CO6511204A2 (es) 2012-08-31
UA108858C2 (xx) 2015-06-25
AR078164A1 (es) 2011-10-19
KR20120055651A (ko) 2012-05-31
SG179055A1 (en) 2012-04-27
HK1218759A1 (zh) 2017-03-10
KR101451486B1 (ko) 2014-10-22
TW201114776A (en) 2011-05-01
WO2011029547A2 (en) 2011-03-17
WO2011029547A8 (en) 2011-06-16
CN102482318B (zh) 2015-11-25
PE20120894A1 (es) 2012-08-13
IL218539A0 (en) 2012-05-31
US20110065678A1 (en) 2011-03-17
HK1166085A1 (zh) 2012-10-19
MA33561B1 (fr) 2012-09-01
AU2010294598B2 (en) 2016-09-01
CN105175479B (zh) 2017-06-09
WO2011029547A3 (en) 2011-08-18
EA201290091A1 (ru) 2012-12-28
AR118123A2 (es) 2021-09-22
JO3760B1 (ar) 2021-01-31
NZ598662A (en) 2014-03-28
SG10201608490VA (en) 2016-11-29
ZA201201705B (en) 2013-05-29
TWI494318B (zh) 2015-08-01
IL218539A (en) 2015-09-24
GEP20146135B (en) 2014-08-11
EP2475676B1 (en) 2020-05-27
EA025191B1 (ru) 2016-11-30
EP2475676A2 (en) 2012-07-18
AU2010294598A1 (en) 2012-04-05
CA2773594C (en) 2018-09-25
MY164842A (en) 2018-01-30
EP2993178A1 (en) 2016-03-09
BR112012005503A2 (pt) 2016-04-19
CN105175479A (zh) 2015-12-23

Similar Documents

Publication Publication Date Title
BR112014014809A2 (pt) composições farmacêuticas compreendendo glitazonas e ativadores de nrf2
DOP2011000402A (es) Composicion farmaceutica para la anticoncepcion de emergencia
NI201300080A (es) Formas sólidas de 3 - ( 5 - amino - 2 - metil - 4 - oxo - 4h - quinazolin - 3 - il ) - piperidin - 2, 6 - diona, y sus composiciones farmacéuticas y usos
UY34104A (es) ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
ECSP12011654A (es) Derivados de 5-fluoropirimidinona
MX355428B (es) Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa.
CL2013000322A1 (es) Compuestos derivados de piperidina sustituida; proceso de preparacion; composicion farmaceutica y su uso para producir un efecto antiproliferativo y/o proapoptotico.
ECSP11011183A (es) Compuestos orgánicos
ECSP11011184A (es) Compuestos orgánicos
ECSP14013339A (es) Compuestos con actividad nematicida
UY32383A (es) Dionas cíclicas herbicidamente activas, derivados, procesos para su preparación composiciones que las comprenden y usos de las mismas
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
BR112015005168A2 (pt) Derivados de c17-alcanodiila e alquenodiila de ácido oleanólico e métodos de uso dos mesmos
UY32918A (es) Nuevos compuestos de 2-piridona
UY34008A (es) ?formas en estado sólido de inhibidor de hiv, composición farmacéutica, uso de la misma, y procesos para preparar dichas formas?.
UY32387A (es) Ciclopentanodionas herbicidamente activas, derivados, procesos para su preparación, composiciones que las comprenden y usos de las mismas
CO6511204A2 (es) Derivados de isoxazolidina
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
TN2013000313A1 (en) Isoxazolidine derivatives
ECSP099481A (es) Compuestos de piridina y su uso como antagonistas de p2y12
NZ705902A (en) Isoxazolidine derivatives
GT200600153A (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
CL2010000743A1 (es) Compuestos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.